Compared to normal tissues, elevated expression levels of CYP2J2 were observed in bladder, kidney, lung, lymphoma, and ovarian cancer types, while suppressed expression levels of CYP2J2 were observed in cervical, colorectal, esophageal, head and neck, and liver cancer types (Figure 1(a)). This evidence concerns the gene CYP2J2 and liver cancer.